{"title":"Autologous Osteoblast-cell Therapy in Orthodontics and Implantology: A Single-center Experience of Nine Patients","authors":"Dilip Deshpande","doi":"10.5005/jp-journals-10012-1184","DOIUrl":null,"url":null,"abstract":"Resorption of bone post tooth extraction is an established fact. In addition to this, pneumatization of maxillary sinuses further reduced the available bone and space for dental implant restoration. Traumatic loss of bone and bone loss due to cystic disease adds another dimension to clinical presentation and management. Various modalities have been used for bone replacement or restoration and are well documented. Here, we present a case series of nine patients, wherein a novel autologous cultured osteoblast cell product was used for bone augmentation in different clinical settings, with a quite satisfactory long-term outcome. We recommend the use of this revolutionary approach in rightly selected patients for permanent bone regeneration in the treatment of various oral and maxillofacial defects.","PeriodicalId":303737,"journal":{"name":"International Journal of Oral Implantology and Clinical Research","volume":"47 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Oral Implantology and Clinical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10012-1184","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Resorption of bone post tooth extraction is an established fact. In addition to this, pneumatization of maxillary sinuses further reduced the available bone and space for dental implant restoration. Traumatic loss of bone and bone loss due to cystic disease adds another dimension to clinical presentation and management. Various modalities have been used for bone replacement or restoration and are well documented. Here, we present a case series of nine patients, wherein a novel autologous cultured osteoblast cell product was used for bone augmentation in different clinical settings, with a quite satisfactory long-term outcome. We recommend the use of this revolutionary approach in rightly selected patients for permanent bone regeneration in the treatment of various oral and maxillofacial defects.